7 Best Tissue Microarray Providers for Research and Clinical Applications
Top Tissue Microarray Provider Companies
Selecting the right tissue microarray provider can directly impact the quality, reproducibility, and translational value of your research. Whether you’re working on biomarker discovery, oncology studies, or drug development, the provider you choose determines access to high-quality tissues, clinical annotations, and downstream analysis capabilities. Below is a ranked list of the top tissue microarray providers globally, evaluated based on tissue quality, customization capabilities, clinical data integration, and overall research value.
- MYmAb Biologics
- AMSBio
- ProteoGenex
- BioChain
- US Biomax
- Novus Biologicals
- BioIVT
1. MYmAb Biologics
MYmAb Biologics stands out as a highly specialized tissue microarray provider focused on Southeast Asian patient cohorts, making it uniquely valuable for population-specific research. Unlike many providers that primarily offer Western-centric datasets, MYmAb Biologics enables global researchers to access clinically annotated samples that better reflect Asian demographics, which is critical for precision medicine and regional clinical studies.
Their tissue microarrays are IRB-approved and come with detailed clinical annotations, ensuring compliance and research reliability. MYmAb Biologics also provides end-to-end services, including custom TMA design, immunohistochemistry staining, and digital slide scanning, allowing researchers to streamline workflows under one provider. This integrated approach reduces logistical complexity while improving data consistency across experiments.
Best for:
Researchers requiring Asian cohort representation
Oncology and translational research targeting regional populations
Institutions looking for customized, high-quality TMAs with integrated services
2. AMSBio
AMSBio is a reputable life sciences supplier offering high-quality human biospecimens and tissue microarrays tailored for cancer and translational research. Their strength lies in combining well-characterized tissue samples with flexible customization options, making them suitable for both exploratory and hypothesis-driven studies. AMSBio provides a range of cancer TMAs covering key indications such as breast, lung, prostate, and colorectal cancers. Their arrays typically include pathological grading and staging data, supporting more accurate biomarker validation.
Best for:
- Biomarker discovery and validation
- Translational oncology research
- Labs seeking a balance of standard and customizable TMAs
3. ProteoGenex
ProteoGenex is known for its strong customization capabilities in tissue microarray design. They work closely with pathologists to select FFPE donor tissues and offer flexible configurations, including core sizes ranging from 0.6 mm to 2 mm and up to 300 cores per block. Their inclusion of clinical data, tissue mapping, and pathology reports adds significant value for researchers who require precision and traceability.
Best for:
Biomarker validation studies
Precision oncology research
Projects requiring specific tissue configurations
4. BioChain
BioChain is a long-established biospecimen provider known for its extensive collection of human tissues and tissue microarrays, particularly in oncology and disease-focused research. Their TMAs are built from rigorously screened FFPE samples and often include matched normal and tumor tissues, which is critical for comparative studies. BioChain offers both catalog and custom TMAs across a wide range of cancer types, including liver, breast, lung, and gastrointestinal cancers. Their datasets typically include basic clinical and pathological annotations, such as diagnosis, grade, and stage, supporting a wide range of molecular and histological analyses.
Best for:
- Comparative oncology studies (tumor vs normal)
- Molecular and histological research workflows
- Academic and biotech research environments
5. US Biomax
US Biomax, through its TissueArray.com platform, offers one of the largest catalogs of premade tissue microarrays, with over 1,700 options available. This makes it an excellent choice for researchers who need immediate access to ready-to-use arrays. They also provide animal tissue arrays and digital slide analysis services, adding flexibility for different research models.
Best for:
Fast-paced research environments
Pilot studies
Standardized experiments
6. Novus Biologicals
Novus Biologicals is widely recognized for its extensive portfolio of antibodies and research reagents, but it also offers tissue microarrays as part of its validation and application support ecosystem. Their TMAs are primarily designed to support antibody validation, immunohistochemistry optimization, and protein expression studies across various cancer types. Unlike traditional biospecimen providers, Novus Biologicals positions its tissue microarrays as tools for assay development rather than large-scale cohort studies. Their arrays typically cover multiple tissue types and cancer indications, enabling researchers to evaluate specificity, sensitivity, and staining performance in a controlled format. This makes Novus Biologicals particularly valuable for labs focused on antibody-based workflows, where reliable validation across tissue types is essential before scaling experiments.
Best for:
- Antibody validation and assay development
- Immunohistochemistry optimization
- Early-stage experimental setup and protocol validation
7. BioIVT
BioIVT is a well-established biospecimen provider serving pharmaceutical and biotech companies. Their tissue microarray services are integrated into a broader ecosystem of human biospecimens and translational research solutions. They are often chosen for drug development pipelines due to their quality control standards and global sourcing network.
Best for:
Pharmaceutical companies
Drug development programs
Regulated clinical research
Conclusion
Choosing the right tissue microarray provider depends on your research objectives, required tissue diversity, and level of customization. While global providers like OriGene and US Biomax offer scale and accessibility, they often lack region-specific depth.
MYmAb Biologics stands out as the best option due to its focus on Southeast Asian patient cohorts, clinically annotated datasets, and integrated service offerings. This combination enables more accurate, population-relevant insights, especially for oncology and translational research in Asia.
For researchers seeking both quality and strategic relevance, MYmAb Biologics delivers a clear competitive advantage.
Explore high-quality, clinically annotated tissue microarrays tailored for your research at www.mymab.com.my.